Solid Tumors clinical trials
Showing 851–900 of 1,133 active trials. Describe your situation to see which ones look like a fit.
- Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
- Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
- SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
- Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy
- The Intersection of Oncology Care and Worker Well-Being
- The Impact of COVID-19 on Pulmonary Procedures
- Detecting HPV DNA in Anal and Cervical Cancers
- Development and Analysis of a Stool Bank for Cancer Patients
- Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
- Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- A Study of a Side Effects and Resource Navigation Program for People With Cancer
- Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
- Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Intratumoral N17350 in Advanced Solid Tumors
- A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
- A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- DBC-664 in Adult Patients With Solid Tumors Associated
- A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
- Evaluation for NCI Surgery Branch Clinical Research Protocols
- DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
- Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
- Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
- Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
- Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
- EXoPERT EMERALD Clinical Study
- DESTINY-PANTUMOUR04
- Pan-tumor MRD Study
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- BostonGene and Exigent Genomic INsight Study
- DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
- Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Global Cardio Oncology Registry
- Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection
- Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
- A Multi Center Study of Sexual Toxicities After Radiotherapy
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Liquid Biopsies in Pediatric Solid Tumors
- The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
- Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- A Multicenter Cancer Biospecimen Collection Study
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
- Pediatric PET/MR Image Registry
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.